Different behaviour of mouse‐human chimeric antibody F(ab')2 fragments of IgG1, IgG2 and IgG4 sub‐class in vivo
Mouse‐human chimeric monoclonal antibodies (MAbs) of 3 different human IgG sub‐classes directed against carcinoembryonic antigen (CEA) have been produced in SP‐0 cells trans‐ fected with genomic chimeric DNA. F(ab')2 fragments were obtained by pepsin digestion of the purified chimeric MAbs of h...
Gespeichert in:
Veröffentlicht in: | International journal of cancer 1992-02, Vol.50 (3), p.416-422 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 422 |
---|---|
container_issue | 3 |
container_start_page | 416 |
container_title | International journal of cancer |
container_volume | 50 |
creator | Buchegger, Franz Pèlegrin, Andre Hardman, Norman Heusser, Christoph Lukas, John Dolci, Wanda Mach, Jean‐Pierre |
description | Mouse‐human chimeric monoclonal antibodies (MAbs) of 3 different human IgG sub‐classes directed against carcinoembryonic antigen (CEA) have been produced in SP‐0 cells trans‐ fected with genomic chimeric DNA. F(ab')2 fragments were obtained by pepsin digestion of the purified chimeric MAbs of human IgG1, IgG2 and IgG4 sub‐class and of parental mouse MAb IgG. The 4 F(ab')2 fragments exhibit similar molecular weight by SDS‐PAGE. They were labelled with 125I or 131I and high binding (80 to 87%) to purified unsolubilized CEA was observed. In vivo, double labelling experiments indicate that the longest biological half‐life and the highest tumour‐localization capacity is obtained with F(ab')2 from chimeric MAb of human IgG2 sub‐class, whereas F(ab')2 from chimeric MAb IgG4 give very low values for these 2 parameters. F(ab')2 from chimeric MAb IgG1 and from parental mouse MAb yield intermediate results in vivo. Our findings should help to select the appropriate human IgG sub‐class to produce chimeric or reshaped MAb F(ab')2 to be used for tumour detection by immunoscintigraphy and for radioimmunotherapy. |
doi_str_mv | 10.1002/ijc.2910500316 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_72790896</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72790896</sourcerecordid><originalsourceid>FETCH-LOGICAL-p1716-1a9dabb4dac4eef62d66c570aba8f7a631b417cb6ef6fc549c193ea13bef9a613</originalsourceid><addsrcrecordid>eNpFUctKAzEUDaLUWt26E7LyAU7NnUdillJtrRTc6Hq4ySRtZB510ql05yf4jX6JKRa6uQ_OA-49hJwDGwJj8Z370MNYAssYS4AfkD4wKSIWQ3ZI-oHAIgEJPyYn3n8wBpCxtEd6IJKMA_SJf3TWmtbUK6rMAteu6VraWFo1nTe_3z-LrsKa6oWrTOs0xXrlVFNs6Pga1dVNTG2L8yqo_VY0nU_gdlvjQCy2Q0p9p4KNLtF76mq6duvmlBxZLL052_UBeR8_vY2eo9nrZDp6mEVLEMAjQFmgUmmBOjXG8rjgXGeCocJ7K5AnoFIQWvGAWZ2lUoNMDEKijJXIIRmQy3_fZdt8dsav8sp5bcoSaxPOy0UsJLuXPBAvdsROVabIl62rsN3kuy8FXP7jX640mz3M8m0EeYgg30eQT19G-y35A4J8e8Y</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72790896</pqid></control><display><type>article</type><title>Different behaviour of mouse‐human chimeric antibody F(ab')2 fragments of IgG1, IgG2 and IgG4 sub‐class in vivo</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Buchegger, Franz ; Pèlegrin, Andre ; Hardman, Norman ; Heusser, Christoph ; Lukas, John ; Dolci, Wanda ; Mach, Jean‐Pierre</creator><creatorcontrib>Buchegger, Franz ; Pèlegrin, Andre ; Hardman, Norman ; Heusser, Christoph ; Lukas, John ; Dolci, Wanda ; Mach, Jean‐Pierre</creatorcontrib><description>Mouse‐human chimeric monoclonal antibodies (MAbs) of 3 different human IgG sub‐classes directed against carcinoembryonic antigen (CEA) have been produced in SP‐0 cells trans‐ fected with genomic chimeric DNA. F(ab')2 fragments were obtained by pepsin digestion of the purified chimeric MAbs of human IgG1, IgG2 and IgG4 sub‐class and of parental mouse MAb IgG. The 4 F(ab')2 fragments exhibit similar molecular weight by SDS‐PAGE. They were labelled with 125I or 131I and high binding (80 to 87%) to purified unsolubilized CEA was observed. In vivo, double labelling experiments indicate that the longest biological half‐life and the highest tumour‐localization capacity is obtained with F(ab')2 from chimeric MAb of human IgG2 sub‐class, whereas F(ab')2 from chimeric MAb IgG4 give very low values for these 2 parameters. F(ab')2 from chimeric MAb IgG1 and from parental mouse MAb yield intermediate results in vivo. Our findings should help to select the appropriate human IgG sub‐class to produce chimeric or reshaped MAb F(ab')2 to be used for tumour detection by immunoscintigraphy and for radioimmunotherapy.</description><identifier>ISSN: 0020-7136</identifier><identifier>EISSN: 1097-0215</identifier><identifier>DOI: 10.1002/ijc.2910500316</identifier><identifier>PMID: 1735611</identifier><language>eng</language><publisher>New York: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Animals ; Antibodies, Monoclonal - chemistry ; Antibodies, Monoclonal - genetics ; Antibodies, Monoclonal - immunology ; Antibody Affinity ; Carcinoembryonic Antigen - immunology ; Colonic Neoplasms - immunology ; Humans ; Immunoglobulin Fab Fragments - chemistry ; Immunoglobulin Fab Fragments - immunology ; Immunoglobulin G - genetics ; Immunoglobulin G - immunology ; Immunoglobulin G - metabolism ; Mice ; Mice, Nude ; Neoplasm Transplantation ; Recombinant Fusion Proteins - immunology ; Structure-Activity Relationship</subject><ispartof>International journal of cancer, 1992-02, Vol.50 (3), p.416-422</ispartof><rights>Copyright © 1992 Wiley‐Liss, Inc., A Wiley Company</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fijc.2910500316$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fijc.2910500316$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1735611$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Buchegger, Franz</creatorcontrib><creatorcontrib>Pèlegrin, Andre</creatorcontrib><creatorcontrib>Hardman, Norman</creatorcontrib><creatorcontrib>Heusser, Christoph</creatorcontrib><creatorcontrib>Lukas, John</creatorcontrib><creatorcontrib>Dolci, Wanda</creatorcontrib><creatorcontrib>Mach, Jean‐Pierre</creatorcontrib><title>Different behaviour of mouse‐human chimeric antibody F(ab')2 fragments of IgG1, IgG2 and IgG4 sub‐class in vivo</title><title>International journal of cancer</title><addtitle>Int J Cancer</addtitle><description>Mouse‐human chimeric monoclonal antibodies (MAbs) of 3 different human IgG sub‐classes directed against carcinoembryonic antigen (CEA) have been produced in SP‐0 cells trans‐ fected with genomic chimeric DNA. F(ab')2 fragments were obtained by pepsin digestion of the purified chimeric MAbs of human IgG1, IgG2 and IgG4 sub‐class and of parental mouse MAb IgG. The 4 F(ab')2 fragments exhibit similar molecular weight by SDS‐PAGE. They were labelled with 125I or 131I and high binding (80 to 87%) to purified unsolubilized CEA was observed. In vivo, double labelling experiments indicate that the longest biological half‐life and the highest tumour‐localization capacity is obtained with F(ab')2 from chimeric MAb of human IgG2 sub‐class, whereas F(ab')2 from chimeric MAb IgG4 give very low values for these 2 parameters. F(ab')2 from chimeric MAb IgG1 and from parental mouse MAb yield intermediate results in vivo. Our findings should help to select the appropriate human IgG sub‐class to produce chimeric or reshaped MAb F(ab')2 to be used for tumour detection by immunoscintigraphy and for radioimmunotherapy.</description><subject>Animals</subject><subject>Antibodies, Monoclonal - chemistry</subject><subject>Antibodies, Monoclonal - genetics</subject><subject>Antibodies, Monoclonal - immunology</subject><subject>Antibody Affinity</subject><subject>Carcinoembryonic Antigen - immunology</subject><subject>Colonic Neoplasms - immunology</subject><subject>Humans</subject><subject>Immunoglobulin Fab Fragments - chemistry</subject><subject>Immunoglobulin Fab Fragments - immunology</subject><subject>Immunoglobulin G - genetics</subject><subject>Immunoglobulin G - immunology</subject><subject>Immunoglobulin G - metabolism</subject><subject>Mice</subject><subject>Mice, Nude</subject><subject>Neoplasm Transplantation</subject><subject>Recombinant Fusion Proteins - immunology</subject><subject>Structure-Activity Relationship</subject><issn>0020-7136</issn><issn>1097-0215</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFUctKAzEUDaLUWt26E7LyAU7NnUdillJtrRTc6Hq4ySRtZB510ql05yf4jX6JKRa6uQ_OA-49hJwDGwJj8Z370MNYAssYS4AfkD4wKSIWQ3ZI-oHAIgEJPyYn3n8wBpCxtEd6IJKMA_SJf3TWmtbUK6rMAteu6VraWFo1nTe_3z-LrsKa6oWrTOs0xXrlVFNs6Pga1dVNTG2L8yqo_VY0nU_gdlvjQCy2Q0p9p4KNLtF76mq6duvmlBxZLL052_UBeR8_vY2eo9nrZDp6mEVLEMAjQFmgUmmBOjXG8rjgXGeCocJ7K5AnoFIQWvGAWZ2lUoNMDEKijJXIIRmQy3_fZdt8dsav8sp5bcoSaxPOy0UsJLuXPBAvdsROVabIl62rsN3kuy8FXP7jX640mz3M8m0EeYgg30eQT19G-y35A4J8e8Y</recordid><startdate>19920201</startdate><enddate>19920201</enddate><creator>Buchegger, Franz</creator><creator>Pèlegrin, Andre</creator><creator>Hardman, Norman</creator><creator>Heusser, Christoph</creator><creator>Lukas, John</creator><creator>Dolci, Wanda</creator><creator>Mach, Jean‐Pierre</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>19920201</creationdate><title>Different behaviour of mouse‐human chimeric antibody F(ab')2 fragments of IgG1, IgG2 and IgG4 sub‐class in vivo</title><author>Buchegger, Franz ; Pèlegrin, Andre ; Hardman, Norman ; Heusser, Christoph ; Lukas, John ; Dolci, Wanda ; Mach, Jean‐Pierre</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p1716-1a9dabb4dac4eef62d66c570aba8f7a631b417cb6ef6fc549c193ea13bef9a613</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>Animals</topic><topic>Antibodies, Monoclonal - chemistry</topic><topic>Antibodies, Monoclonal - genetics</topic><topic>Antibodies, Monoclonal - immunology</topic><topic>Antibody Affinity</topic><topic>Carcinoembryonic Antigen - immunology</topic><topic>Colonic Neoplasms - immunology</topic><topic>Humans</topic><topic>Immunoglobulin Fab Fragments - chemistry</topic><topic>Immunoglobulin Fab Fragments - immunology</topic><topic>Immunoglobulin G - genetics</topic><topic>Immunoglobulin G - immunology</topic><topic>Immunoglobulin G - metabolism</topic><topic>Mice</topic><topic>Mice, Nude</topic><topic>Neoplasm Transplantation</topic><topic>Recombinant Fusion Proteins - immunology</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Buchegger, Franz</creatorcontrib><creatorcontrib>Pèlegrin, Andre</creatorcontrib><creatorcontrib>Hardman, Norman</creatorcontrib><creatorcontrib>Heusser, Christoph</creatorcontrib><creatorcontrib>Lukas, John</creatorcontrib><creatorcontrib>Dolci, Wanda</creatorcontrib><creatorcontrib>Mach, Jean‐Pierre</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Buchegger, Franz</au><au>Pèlegrin, Andre</au><au>Hardman, Norman</au><au>Heusser, Christoph</au><au>Lukas, John</au><au>Dolci, Wanda</au><au>Mach, Jean‐Pierre</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Different behaviour of mouse‐human chimeric antibody F(ab')2 fragments of IgG1, IgG2 and IgG4 sub‐class in vivo</atitle><jtitle>International journal of cancer</jtitle><addtitle>Int J Cancer</addtitle><date>1992-02-01</date><risdate>1992</risdate><volume>50</volume><issue>3</issue><spage>416</spage><epage>422</epage><pages>416-422</pages><issn>0020-7136</issn><eissn>1097-0215</eissn><abstract>Mouse‐human chimeric monoclonal antibodies (MAbs) of 3 different human IgG sub‐classes directed against carcinoembryonic antigen (CEA) have been produced in SP‐0 cells trans‐ fected with genomic chimeric DNA. F(ab')2 fragments were obtained by pepsin digestion of the purified chimeric MAbs of human IgG1, IgG2 and IgG4 sub‐class and of parental mouse MAb IgG. The 4 F(ab')2 fragments exhibit similar molecular weight by SDS‐PAGE. They were labelled with 125I or 131I and high binding (80 to 87%) to purified unsolubilized CEA was observed. In vivo, double labelling experiments indicate that the longest biological half‐life and the highest tumour‐localization capacity is obtained with F(ab')2 from chimeric MAb of human IgG2 sub‐class, whereas F(ab')2 from chimeric MAb IgG4 give very low values for these 2 parameters. F(ab')2 from chimeric MAb IgG1 and from parental mouse MAb yield intermediate results in vivo. Our findings should help to select the appropriate human IgG sub‐class to produce chimeric or reshaped MAb F(ab')2 to be used for tumour detection by immunoscintigraphy and for radioimmunotherapy.</abstract><cop>New York</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>1735611</pmid><doi>10.1002/ijc.2910500316</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0020-7136 |
ispartof | International journal of cancer, 1992-02, Vol.50 (3), p.416-422 |
issn | 0020-7136 1097-0215 |
language | eng |
recordid | cdi_proquest_miscellaneous_72790896 |
source | MEDLINE; Access via Wiley Online Library |
subjects | Animals Antibodies, Monoclonal - chemistry Antibodies, Monoclonal - genetics Antibodies, Monoclonal - immunology Antibody Affinity Carcinoembryonic Antigen - immunology Colonic Neoplasms - immunology Humans Immunoglobulin Fab Fragments - chemistry Immunoglobulin Fab Fragments - immunology Immunoglobulin G - genetics Immunoglobulin G - immunology Immunoglobulin G - metabolism Mice Mice, Nude Neoplasm Transplantation Recombinant Fusion Proteins - immunology Structure-Activity Relationship |
title | Different behaviour of mouse‐human chimeric antibody F(ab')2 fragments of IgG1, IgG2 and IgG4 sub‐class in vivo |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T20%3A23%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Different%20behaviour%20of%20mouse%E2%80%90human%20chimeric%20antibody%20F(ab')2%20fragments%20of%20IgG1,%20IgG2%20and%20IgG4%20sub%E2%80%90class%20in%20vivo&rft.jtitle=International%20journal%20of%20cancer&rft.au=Buchegger,%20Franz&rft.date=1992-02-01&rft.volume=50&rft.issue=3&rft.spage=416&rft.epage=422&rft.pages=416-422&rft.issn=0020-7136&rft.eissn=1097-0215&rft_id=info:doi/10.1002/ijc.2910500316&rft_dat=%3Cproquest_pubme%3E72790896%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72790896&rft_id=info:pmid/1735611&rfr_iscdi=true |